Use of incentives to increase compliance for TB screening in a population of intravenous drug users

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 2, 1999, Pages 153-155

  Fitzgerald, J Mark ^a,b   Patrick, D M ^a   Strathdee, S ^a   Rekart, M ^a   Elwood, R K ^a   Schecter, M T ^a   Montaner, J ^a   O'Shaughnessy, M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Compliance; Incentives; Intravenous drug users; PPD skin testing; Screening; Tuberculosis

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; CANADA; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MONEY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; BRITISH COLUMBIA; FEMALE; HUMANS; MALE; MOTIVATION; PATIENT COMPLIANCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0033034739     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Perlman D C, Salomon N, Perkins M P, Yancovitz S, Paone D, Des Jarlais D C. Tuberculosis in drug users. Clin Infect Dis 1995; 21: 1253-1264.
2. Reichman L B, Felton C P, Edsall J R. Drug dependence: a new risk factor for tuberculosis disease. Arch Intern Med 1979; 139: 337-339.
3. Selwyn P A, Hartel D, Lewis V A, et al. A prospective study of the risk of tuberculosis in intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
4. Canadian Tuberculosis Standards. FitzGerald, J Mark, ed. Ottawa 1996.
5. Chaisson R E, Keruly J C, McAvinue S, Gallant J E, Moore R D. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J AIDS Human Retrovirol 1996; 11: 445-459.
6. Blenkush M, Kunimoto D, Black W, Elwood R K, FitzGerald J M. Evidence for TB clustering in Vancouver: results from a pilot study using RFLP fingerprinting. Can Com Dis Report 1996; 22-7: 49-51.
7. Heal G, Elwood R K, Farley J, FitzGerald J M. Results of directly observed intermittent versus daily isoniazid chemoprophylaxis preventive therapy in Aboriginal people. Am J Respir Crit Care Med 1997; 155 (suppl): Abstract A563.
8. Giuffrida A, Torgerson D J. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997; 315: 703-707.
9. Morisky D E, Malotte C K, Choi P, et al. A patient education program to improve adherence rates with anti-tuberculosis drug regimens. Health Educ Q 1990; 17: 253-267.
10. Blenkush M, Korzeniewska-Kosela M, Elwood R K, Black W A, FitzGerald J M. HIV-related tuberculosis in British Columbia: indications of a rise and change in risk groups. Clin Invest Med 1996; 19: 271-278.